MedTrace Logo

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

NCT06729021 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2025-03-18

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are:

Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population?

Participants will:

Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay.

Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.

Conditions

  • DVT - Deep Vein Thrombosis

Interventions

DEVICE

GCS

Graduated compression stockings may be used after procedure by the decision of the doctor

DRUG

LMWH

Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Sponsors & Collaborators

  • Al-Nahrain University

    lead OTHER

Principal Investigators

  • Yaser aamer Eisa Alhaibi, Assistant professor · College Of Medicine - Nahrain University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-20
Primary Completion
2025-07-20
Completion
2025-07-30

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06729021 on ClinicalTrials.gov